Profile of Patients Treated with Intravitreal Antiangiogenics in Brazil
Author Information
Author(s): Isadora Andrade Rabelo, Marina Crespo Soares, Andrea Mara Simões Torigoe
Primary Institution: Hospital das Clínicas, Universidade Estadual de Campinas, Campinas, SP, Brazil
Hypothesis
This study aimed to describe the clinical and epidemiological profile of patients undergoing intravitreal antiangiogenic therapy in a tertiary referral hospital in Brazil.
Conclusion
The study provides insights into the clinical and epidemiological profile of patients receiving antiangiogenic therapy, highlighting the need for better understanding and optimization of treatment in Brazil.
Supporting Evidence
- Bevacizumab was the most commonly used intravitreal injectable medicine (79.38%).
- Macular edema was the most prevalent pathology indicative of treatment (60.12%).
- Treatment adherence was associated with the patient’s pathology.
Takeaway
Doctors looked at the health records of 429 patients who got eye injections to help with vision problems. They found that many patients didn't follow their treatment plans.
Methodology
This cross-sectional, retrospective, and observational study analyzed medical records of patients who received intravitreal injections of antiangiogenic agents for retinal diseases.
Limitations
The study had a short follow-up period, which may limit the conclusions drawn.
Participant Demographics
The majority of patients were male (51.28%), white (80.89%), aged between 50 and 80 years (mean age 60.92), and had primary education (56.88%).
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website